Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.

Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10-15% of women during reproductive age and has a big personal and social impact due to chronic pelvic pain, subfertility, loss of work-hours and medical costs. Such conditions are exacerbated by the fact t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marc H Schreinemacher, Walter H Backes, Jos M Slenter, Sofia Xanthoulea, Bert Delvoux, Larissa van Winden, Regina G Beets-Tan, Johannes L H Evers, Gerard A J Dunselman, Andrea Romano
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f5fb2e8550154cd19f39ec5ae17c99fe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f5fb2e8550154cd19f39ec5ae17c99fe
record_format dspace
spelling oai:doaj.org-article:f5fb2e8550154cd19f39ec5ae17c99fe2021-11-18T07:24:28ZTowards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.1932-620310.1371/journal.pone.0033241https://doaj.org/article/f5fb2e8550154cd19f39ec5ae17c99fe2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22457748/?tool=EBIhttps://doaj.org/toc/1932-6203Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10-15% of women during reproductive age and has a big personal and social impact due to chronic pelvic pain, subfertility, loss of work-hours and medical costs. Such conditions are exacerbated by the fact that the correct diagnosis is made as late as 8-11 years after symptom presentation. This is due to the lack of a reliable non-invasive diagnostic test and the fact that the reference diagnostic standard is laparoscopy (invasive, expensive and not without risks). High-molecular weight gadofosveset-trisodium is used as contrast agent in Magnetic Resonance Imaging (MRI). Since it extravasates from hyperpermeable vessels more easily than from mature blood vessels, this contrast agent detects angiogenesis efficiently. Endometriosis has high angiogenic activity. Therefore, we have tested the possibility to detect endometriosis non-invasively using Dynamic Contrast-Enhanced MRI (DCE-MRI) and gadofosveset-trisodium as a contrast agent in a mouse model. Endometriotic lesions were surgically induced in nine mice by autologous transplantation. Three weeks after lesion induction, mice were scanned by DCE-MRI. Dynamic image analysis showed that the rates of uptake (inwash), persistence and outwash of the contrast agent were different between endometriosis and control tissues (large blood vessels and back muscle). Due to the extensive angiogenesis in induced lesions, the contrast agent persisted longer in endometriotic than control tissues, thus enhancing the MRI signal intensity. DCE-MRI was repeated five weeks after lesion induction, and contrast enhancement was similar to that observed three weeks after endometriosis induction. The endothelial-cell marker CD31 and the pericyte marker α-smooth-muscle-actin (mature vessels) were detected with immunohistochemistry and confirmed that endometriotic lesions had significantly higher prevalence of new vessels (CD31 only positive) than the uterus and control tissues. The diagnostic value of gadofosveset-trisodium to detect endometriosis should be tested in human settings.Marc H SchreinemacherWalter H BackesJos M SlenterSofia XanthouleaBert DelvouxLarissa van WindenRegina G Beets-TanJohannes L H EversGerard A J DunselmanAndrea RomanoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 3, p e33241 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marc H Schreinemacher
Walter H Backes
Jos M Slenter
Sofia Xanthoulea
Bert Delvoux
Larissa van Winden
Regina G Beets-Tan
Johannes L H Evers
Gerard A J Dunselman
Andrea Romano
Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.
description Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10-15% of women during reproductive age and has a big personal and social impact due to chronic pelvic pain, subfertility, loss of work-hours and medical costs. Such conditions are exacerbated by the fact that the correct diagnosis is made as late as 8-11 years after symptom presentation. This is due to the lack of a reliable non-invasive diagnostic test and the fact that the reference diagnostic standard is laparoscopy (invasive, expensive and not without risks). High-molecular weight gadofosveset-trisodium is used as contrast agent in Magnetic Resonance Imaging (MRI). Since it extravasates from hyperpermeable vessels more easily than from mature blood vessels, this contrast agent detects angiogenesis efficiently. Endometriosis has high angiogenic activity. Therefore, we have tested the possibility to detect endometriosis non-invasively using Dynamic Contrast-Enhanced MRI (DCE-MRI) and gadofosveset-trisodium as a contrast agent in a mouse model. Endometriotic lesions were surgically induced in nine mice by autologous transplantation. Three weeks after lesion induction, mice were scanned by DCE-MRI. Dynamic image analysis showed that the rates of uptake (inwash), persistence and outwash of the contrast agent were different between endometriosis and control tissues (large blood vessels and back muscle). Due to the extensive angiogenesis in induced lesions, the contrast agent persisted longer in endometriotic than control tissues, thus enhancing the MRI signal intensity. DCE-MRI was repeated five weeks after lesion induction, and contrast enhancement was similar to that observed three weeks after endometriosis induction. The endothelial-cell marker CD31 and the pericyte marker α-smooth-muscle-actin (mature vessels) were detected with immunohistochemistry and confirmed that endometriotic lesions had significantly higher prevalence of new vessels (CD31 only positive) than the uterus and control tissues. The diagnostic value of gadofosveset-trisodium to detect endometriosis should be tested in human settings.
format article
author Marc H Schreinemacher
Walter H Backes
Jos M Slenter
Sofia Xanthoulea
Bert Delvoux
Larissa van Winden
Regina G Beets-Tan
Johannes L H Evers
Gerard A J Dunselman
Andrea Romano
author_facet Marc H Schreinemacher
Walter H Backes
Jos M Slenter
Sofia Xanthoulea
Bert Delvoux
Larissa van Winden
Regina G Beets-Tan
Johannes L H Evers
Gerard A J Dunselman
Andrea Romano
author_sort Marc H Schreinemacher
title Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.
title_short Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.
title_full Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.
title_fullStr Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.
title_full_unstemmed Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.
title_sort towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/f5fb2e8550154cd19f39ec5ae17c99fe
work_keys_str_mv AT marchschreinemacher towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT walterhbackes towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT josmslenter towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT sofiaxanthoulea towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT bertdelvoux towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT larissavanwinden towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT reginagbeetstan towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT johanneslhevers towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT gerardajdunselman towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
AT andrearomano towardsendometriosisdiagnosisbygadofosvesettrisodiumenhancedmagneticresonanceimaging
_version_ 1718423510201663488